— Know what they know.
Not Investment Advice

PASG NASDAQ

Passage Bio, Inc.
1W: -14.2% 1M: -10.6% 3M: -12.3% YTD: -64.8% 1Y: -49.3% 3Y: -69.0% 5Y: -98.0%
$4.12
-0.08 (-1.93%)
 
Weekly Expected Move ±6.7%
$4 $4 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 33 · $13.2M mcap · 3M float · 1.93% daily turnover · Short 26% of daily vol

Balance Sheet Trends

Total Assets
$62M -39.2% ▼
5Y CAGR: -28.3%
Total Liabilities
$44M +5.8% ▲
5Y CAGR: +13.3%
Shareholders Equity
$19M -69.4% ▼
5Y CAGR: -42.7%
Cash & Investments
$46M -39.7% ▼
5Y CAGR: -31.4%
Total Debt
$24M -5.8% ▼
Net Debt
-$22M -84.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$129M$35M$22M$38M$46M
Short-Term Investments$187M$155M$93M$39M$0
Cash & ST Investments$316M$190M$114M$77M$46M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$2M$926K$923K$838K$1M
Total Current Assets$325M$197M$118M$79M$48M
Property, Plant & Equip.$24M$42M$32M$23M$14M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$6M$4M$433K$463K$244K
Total Non-Current Assets$30M$47M$33M$24M$15M
Total Assets$355M$244M$151M$102M$62M
— Liabilities —
Accounts Payable$9M$4M$1M$742K$1M
Short-Term Debt$0$0$0$4M$4M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$661K$85K$7M$11M$18M
Total Current Liabilities$29M$18M$16M$19M$23M
Long-Term Debt$0$0$0$0$20M
Other Non-Current Liab.$7M$0$0$0$0
Total Non-Current Liabilities$7M$24M$23M$22M$20M
Total Liabilities$36M$42M$39M$41M$44M
— Equity —
Common Stock$5K$5K$5K$6K$0
Retained Earnings-$356M-$492M-$594M-$659M-$705M
Accumulated OCI-$413K-$966K-$43K$8K$0
Total Stockholders Equity$319M$201M$111M$61M$19M
Total Liabilities & Equity$355M$244M$151M$102M$62M
— Key Metrics —
Total Debt$0$27M$26M$25M$24M
Net Debt-$129M-$7M$5M-$12M-$22M
Total Investments$187M$155M$93M$39M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms